Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

Authors: Chanhee Han, Stefania Bellone, Peter E. Schwartz, Serengulam V. Govindan, Robert M. Sharkey, David M. Goldenberg, Alessandro D. Santin

Published: 2018-05-23

DOI: 10.1016/j.gore.2018.05.009

Source: Full article

---

Abstract

No abstract found.